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GD3 Accumulation in Cell Surface Lipid Rafts Prior to Mitochondrial 
Targeting Contributes to Amyloid-β-induced Apoptosis
Neuronal apoptosis induced by amyloid β-peptide (Aβ) plays an important role in the 
pathophysiology of Alzheimer’s disease (AD). However, the molecular mechanism 
underlying Aβ-induced apoptosis remains undetermined. The disialoganglioside GD3 
involves ceramide-, Fas- and TNF-α-mediated apoptosis in lymphoid cells and hepatocytes. 
Although the implication of GD3 has been suggested, the precise role of GD3 in Aβ-
induced apoptosis is still unclear. Here, we investsigated the changes of GD3 metabolism 
and characterized the distribution and trafficking of GD3 during Aβ-induced apoptosis 
using human brain-derived TE671 cells. Extracellular Aβ-induced apoptosis in a 
mitochondrial-dependent manner. GD3 level was negligible in the basal condition. 
However, in response to extracellular Aβ, both the expression of GD3 synthase mRNA and 
the intracellular GD3 level were dramatically increased. Neosynthesized GD3 rapidly 
accumulated in cell surface lipid microdomains, and was then translocated to mitochondria 
to execute the apoptosis. Disruption of membrane lipid microdomains with methyl-β-
cyclodextrin significantly prevented both GD3 accumulation in cell surface and Aβ-induced 
apoptosis. Our data suggest that rapidly accumulated GD3 in plasma membrane lipid 
microdomains prior to mitochondrial translocation is one of the key events in Aβ-induced 
apoptosis.
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ORIGINAL ARTICLE
Neuroscience
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative 
disease of the central nervous system associated with deterio-
ration of cognition and memory, resulting in dementia (1). Char-
acteristic changes in the brain of AD include diffuse loss of neu-
rons, intracellular protein deposits termed neurofibrillary tan-
gles (NFT) consisting of hyperphosphorylated tau protein and 
extracellular protein deposits termed senile plaques (1). Amy-
loid β-peptide (Aβ), a major component of senile plaques, is a 
39 to 43-amino acid peptide derived by the cleavage of the am-
yloid precursor protein (2). Several lines of evidence indicate 
that fibrillar Aβ and, especially, soluble Aβ aggregates are im-
portant in the pathophysiology of AD (2). Neurotoxicity medi-
ated by Aβ has been well established in vitro as well as in vivo 
studies using postmortem brain tissues of AD (1, 2). However, 
molecular determinants of Aβ-induced neuronal death are still 
poorly identified. 
  Gangliosides, sialic acid-containing glycosphingolipids, con-
stitute essential components of the cell membrane and are in-
volved in the modulation of neuronal cell death as well as pro-
liferation and differentiation (3). The disialoganglioside GD3 is 
highly expressed in embryonic nervous system, declining dra-
matically with embryonic development and remaining low in 
the normal adult brain (4). GD3 has attracted attention due to 
its emerging role as an effector of apoptosis (5). Intracellular 
GD3 has been reported to increase in response to ceramide, 
Fas or TNF-α in lymphoid cells and to mediate the early stages 
of apoptotic process (6-8). It has been reported that Aβ-induced 
synthesis of GD3 also contributes the development of apoptosis 
in cortical neurons (9). However, the role of GD3 action in Aβ-
induced apoptosis is still unclear. Therefore, this study was un-
dertaken to confirm the changes of GD3 metabolism and to 
characterize the distribution and trafficking of GD3 during Aβ-
induced apoptosis in nerve cells.
MATERIALS AND METHODS
Reagents
Ganglioside mixture and GD3 were purchased from Alexis Co 
(San Diego, CA, USA) and anti-GD3 monoclonal antibody was 
from Seikagaku Co (Tokyo, Japan). Synthetic amyloid β-protein 
fragment 25-35 and anti-mouse μ-chain specific IgM–peroxi-
dase were purchased from Sigma-Aldrich (St. Louis, MO, USA). Kim J-K, et al.  •  Cell Surface GD3 Accumulation in Amyloid-β-induced Apoptosis
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5,5’ ,6,6’-Tetrachloro-1,1’ ,3,3’-tetraethylbenzimidazol carbocya-
nine iodide (JC-1) was obtained from Molecular Probes (Eugene, 
OR, USA). Annexin V-Fluorescein isothiocynate (FITC) was ob-
tained from BD Biosciences Pharmingen (San Jose, CA, USA). 
All the other drugs except where indicated were purchased from 
Sigma (St. Louis, MO, USA).
Cell culture
Human brain-derived TE671 cells were obtained from Ameri-
can Type Culture Collection (ATCC), and maintained with Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 
L-glutamine (2 mM), antibiotics (100 U/mL penicillin, 100 mg/
mL streptomycin sulfate) and 10% fetal calf serum at 37°C with 
5% CO2 in air atmosphere. At 90% confluence, cells were serum-
deprived overnight for the experiments.
Assessment of apoptosis
Apoptosis was induced by incubating cells with culture medium 
containing synthetic Aβ fragment (40 μM), GD3 (100 μM) and 
H2O2 (0.5 mg/mL) for the indicated times. The quantification of 
apoptotic cells was screened by flow cytometry technique using 
propidium iodide (PI). Cells were fixed 70% ethanol containing 
0.2% Tween 20 and stained with PBS containing PI and RNase. 
Fluorescence was measured using a FACScan cytometry system 
(Beckman Coulter Epics XL, Palo Alto, CA, USA). The apoptosis 
was also quantified by dual-color flow cytometry technique us-
ing the annexin V conjugated with Alexa Fluor 488 and PI. Cells 
were prepared as described above except resuspending in an-
nexin binding reagents for 15 min in the dark without fixation 
step. 
  To determine the changes in MMP after treatment with vari-
ous apoptotic stressors, cells were incubated with culture me-
dium containing JC-1 (1 µM) for 30 min at 37°C, and JC-1 fluo-
rescence was measured by flow cytometry. Mitochondrial in-
tegrity was assessed by fluorescence of Mito Tracker Red, and 
cleavage of caspase-9 and poly (ADP-ribose) polymerase (PARP) 
were analyzed by western blotting.
Measurement of cell surface GD3 
Level of cell surface GD3 was measured by flow cytometry. Cells 
grown on the 6 well plates were washed with ice-cold phosphate 
buffered saline (PBS), and incubated with PBS containing mouse 
anti-GD3 antibody (1:100) at 4°C. After washing with PBS, cells 
were incubated with FITC-labeled goat anti-mouse IgM (1:200). 
Labeled cells were analyzed using flow cytometry.
Measurement of intracellular GD3 by thin layer 
chromatography (TLC) immunostaining
To measure the intracellular GD3 levels, cells grown on 10 cm 
culture dishes were stimulated with various apoptotic stressors 
and then harvested. Cell pellets were centrifuged and dehyda-
rated by freeze dryer (Eyela FD-1000, Tokyo Rikakikai Co, Japan). 
To remove neutral lipids, dried cell powder was resuspended in 
chloroform/methanol (8:2) and sonicated for 30 min at 20°C. 
Crude gangliosides were extracted from pellet by resuspension 
with chloroform/methanol/water (2:8:0.5) and sonication. Gan-
glioside samples were loaded with glass capillary (5 μL) on a sil-
ica gel TLC plate (Merck, Darmstadt, Germany) pre-run in chlo-
roform/methanol/0.2% CaCl2 (55:45:10). Authentic GD3 was 
used as standard. After chromatographed in the same solution, 
plates were treated with 0.4% poly-iso-butyl-metacrylate in hex-
ane, washed with PBS containing 0.1% Tween 20 and blocked 
for an hour in PBS with 1% bovine serum albumin. To carry out 
immunostaining for GD3, the plate was incubated overnight at 
4°C with anti-GD3 monoclonal antibody (1:2,000), followed by 
incubation for an hour at room temperature with a horseradish 
peroxidase-conjugated anti-IgM secondary antibody (1:1,000). 
Specifically stained bands were detected by advanced enhanced 
chemiluminescence (Amersham Biosciences, Buckingham-
shire, UK) with LAS-3000 (Fujifilm, Tokyo, Japan).
Real-time reverse transcriptase-PCR analysis of GD3 
synthase 
Total RNA was extracted using a TRI reagent (Molecular Re-
search Center, Cincinnati, OH, USA). The cDNA was synthe-
sized using 2 µg of RNA and 10 ng/μL of oligo (dT) 15 primer,         
1 mM of dNTP, 200 U of M-MLV Reverse Transcriptase (RT) 
and 1X M-MLV RT buffer (Promega Corporation, Madison, WI, 
USA). The ABI PRISM
® 7000 Sequence Detection System (Ap-
plied Biosystems, Foster City, CA,USA) was used for real-time 
RT-PCR amplification and detection. Real-time RT-PCR was 
prepared of 25 μL reaction mixture in MicroAmp optical 96-well 
reaction plates and sealed with optical adhesive covers (Applied 
Biosystems). Each reaction well contains 1 μL of template DNA, 
12.5 μL of SYBR
® Green PCR Master Mix (Applied Biosystems, 
Warrington, UK), and 3 pM of forward and reverse primers. Am-
plification of GD3 synthase cDNA was performed using the fol-
lowing primers: forward (5´-CCCGAGGAATTTCTCCAACTC-3´) 
and reverse (5´-GCATTCTCAGTGCACCGATTT-3´). Human 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 
used as an internal control. Reaction conditions included an 
initial denaturation step (94°C for 10 min) followed by 40 cycles 
of 95°C for 15 sec, 58°C for 1 min, and 72°C for 30 sec. A final ex-
tension step (72°C for 10 min) concluded the reaction.
Analysis of GD3 localization by confocal microscopy
Cells grown on Lab-Tek 8 well chamber slides were treated with 
Aβ alone or with methyl-β-cyclodextrin (MβCD) for the indi-
cated time periods. After incubated with Mito Tracker Red for 
30 min at 37°C, cells were fixed in 4% paraformaldehyde for 15 
min at room temperature, permeabilized with 0.2% Triton X-100 
for 15 min and labeled with mouse anti-GD3 antibody alone or Kim J-K, et al.  •  Cell Surface GD3 Accumulation in Amyloid-β-induced Apoptosis
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in combination with rabbit anti-caveolin-1 antibody 1 hr at room 
temperature. Cells were washed three times with PBS, and then 
FITC-conjugated anti-mouse IgM alone or in combination with 
Texas Red-conjugated anti-rabbit IgG was applied for 45 min at 
room temperature. After washing three times with PBS, the slides 
were mounted and examined under the confocal laser scan-
ning microscope (LSM 510, Carl Zeiss, Germany).
 
Statistical analysis
Four independent assays were performed. Statistical results 
were expressed as mean±standard deviation of the means ob-
tained from each independent experiment. The results of the 
experimental and control groups were tested for statistical sig-
nificance by a one-tailed Student’s t test.
RESULTS
The extracellular Aβ-induced apoptosis in human 
brain-derived cells
To investigate the capacity of extracellular soluble Aβ to induce 
apoptosis, human medulloblastoma TE671 cells, which are 
known to have neuron-like features (10), were treated with             
40 µM of Aβ for 24 hr and analyzed by flow cytometry using PI 
alone or with annexin V-FITC. As shown in Fig. 1, 24 hr treat-
ment of Aβ induced 37% apoptosis. TE671 cells were more sus-
ceptible to an apoptosis induced by an oxidative stressor, H2O2 
than Aβ. However, extracellular GD3 failed to induce a signifi-
cant apoptosis in nerve cells after 24 hr treatment at the con-
centrations up to 100 µM. 
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Fig. 1. Amyloid β-induced apoptosis. TE671 cells were treated with GD3 (100 µM), Aβ (40 µM) or H2O2 (0.5 mg/mL) for 24 hr. Apoptotic cell death was quantified by flow 
cytometry analysis using PI alone (A) or with annexin V-FITC (B). Results are given as the mean±S.D. of four individual experiments (C). 
*P<0.01.
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Fig. 2. Mitochondrial involvement in 
amyloid β-induced apoptosis. (A) TE671 
cells were exposed to GD3 (100 µM), Aβ 
(40 µM) or H2O2 (0.5 mg/mL) for 8 hr. 
Dissipation of mitochondrial membrane 
potential was assessed by shift of JC-1 
aggregates from red to green fluorescence 
using flow cytometry. Numbers represent 
percent of cells in the lower right quadrant. 
(B) Mitochondrial integrity was evaluated 
using Mito Tracker Red after 24 hr of Aβ 
treatments. (C) Caspase 9 and PARP acti-
vation after Aβ treatment were assessed 
by western blotting using cells lysates.Kim J-K, et al.  •  Cell Surface GD3 Accumulation in Amyloid-β-induced Apoptosis
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Mitochondrial involvement in Aβ-induced apoptosis
To examine whether Aβ-induced apoptosis in TE671 cells is link-
ed to mitochondrial functional damage, mitochondrial changes 
after Aβ treatment were assessed. Cells were stained with JC-1, 
a dye sensitive to the changes in mitochondrial membrane po-
tential. As shown in Fig. 2A, control cells showed the typical or-
ange-red fluorescence of J-aggregates at polarized mitochon-
drial membrane potential. Aβ stimulation for 8 hr to the cells 
induced increase in green fluorescence of JC-1 monomeric form 
(0.08% in control; 6.38% in Aβ-treated cells), indicating the col-
lapse of mitochondrial membrane potential. H2O2 treatment 
caused 19.78% of the cells to lose mitochondrial membrane po-
tential. Aβ-induced mitochondrial damage was further assessed 
with Mito Tracker Red, a fluorescent mitochondria-specific mark-
er (Fig. 2B). In untreated cells, Mito Tracker was sequestrated in 
the intact mitochondria appearing as discrete puncta around 
nucleus. Treatment of Aβ for 24 hr induced Mito Tracker to dis-
tribute uniformly in the cytoplasm, indicative of disruption of 
the mitochondrial integrity. Caspase-9, an important down-
stream target of cytochrome c release in apoptosome pathway, 
and poly (ADP-ribose) polymerase (PARP), were activated in 
cells exposed to Aβ treatment (Fig. 2C). These results show that 
Aβ-induced apoptosis in nerve cells is linked to mitochondrial 
damage.
Increased GD3 synthesis during Aβ-induced apoptosis
To investigate whether extracellular Aβ induces any change in 
GD3 metabolism, we analyzed the intracellular level of GD3 in 
TE671 cells. TLC analysis combined with immunodetection 
showed a prominent increase of intracellular GD3 content 16 
hrs after addition of extracellular Aβ (Fig. 3A). However, no sig-
nificant increase in intracellular GD3 levels was detected in 
cells exposed to H2O2. 
  Because GD3 synthase is responsible for GD3 synthesis from 
its precursor ganglioside GM3, we examined whether Aβ-induc-
ed increase in intracellular GD3 level is related with expression 
of GD3 synthase. Quantitative real-time RT-PCR revealed that 
the expression of GD3 synthase mRNA was 14 fold increased at 
4 hr of Aβ addition to TE671 cells (Fig. 3B). However, H2O2 treat-
ment did not affect significantly the expression of GD3 synthase 
mRNA.
Subcellular trafficking of synthesized GD3 during  
Aβ-induced apoptosis
Having shown that neosynthesized GD3 is redistributed to nu-
cleus or mitochondria during CD95/Fas- or TNF α–mediated 
apoptosis (9, 14), we investigated the subcellular trafficking of 
GD3 during Aβ-induced apoptosis using confocal immunoflu-
orescent study. In untreated basal condition, GD3 staining was 
negligibly low as a whole except some spots surrounding nucle-
us and cell periphery (Fig. 3C, D). Interestingly, exposure to ex-
tracellular Aβ induced accumulation of GD3 in particular regions 
of cell surface within an hour (Fig. 3C). Colocalization study show-
ed that GD3 signal in the cell surface was partially overlapped 
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Fig. 3. GD3 synthesis and traffick  ing during amyloid β-induced apop  tosis. (A) TE671 cells were treated with either Aβ (40 µM) or H2O2 (0.5 mg/mL) for 16 hr. Intracellular GD3 
levels were measured by thin layer chromatography immunostaining using the crude ganglioside cell extracts. (B) Expression of GD3 synthase after 4 hr of Aβ treatment was 
analyzed by real-time quan  titative RT-PCR using GAPDH as an internal control. Results are given as the mean±S.D. of four individual experiments. *P<0.01. (C) Locali  zation of 
intracellular GD3 after Aβ treatment was evaluated by double immunofluorescence staining tech  nique with FITC-labeled anti-GD3 and Texas Red-labeled anti-caveolin-1 
antibodies. (D) Cells were loaded with Mito Tracker Red for 30 min before fixation and then labeled with FITC-conjugated anti-GD3 antibody. (E) Cell surface GD3 levels after 4 
hr of Aβ treatment were analyzed by flow cytometry using FITC-labeled anti-GD3 antibody. 
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with that of caveolin-1, a membrane caveolae marker. Aβ-induc-
ed GD3 accumulation in plasma membrane was peaked at 4 hr, 
and then dispersed to re-accumulate as clusters of puncta around 
nucleus after 8 hr of Aβ treatment (Fig. 3D). Punctate pattern of 
GD3 surrounding nucleus was coincided with that of Mito Track-
er. However, trafficking of GD3 to nucleus after Aβ stimulation 
was not observed in TE671 cells. These findings suggest that 
neosynthesized GD3 in response to extracellular Aβ accumu-
lates in the plasma membrane before targeting to its final desti-
nation, mitochondria. 
  Accumulation of GD3 in cell surface after Aβ treatment was 
also confirmed by flow cytometry analysis. Fig. 3E shows that 
the cell surface GD3 level increased at 4 hr after Aβ addition, 
whereas H2O2 treatment did not induce any significant change.
Blockage of Aβ-induced apoptosis by inhibition of GD3 
accumulation and trafficking 
Finally, we investigated whether perturbation of GD3 accumu-
lation in cell surface and its targeting to mitochondria could pre-
vent Aβ-induced apoptosis. Experiments were carried out by 
preincubating cells with MβCD to deplete membrane lipid mi-
crodomains of either plasma membrane or mitochondrial mem-
brane. As shown in Fig. 4A, MβCD treatment resulted in round 
cell morphology with loss of caveolin-1-postive puncta along 
the cell periphery. Both immunofluorescent microscopy and 
flow cytometry analysis revealed that MβCD blocked Aβ-induced 
GD3 accumulation in plasma membrane (Fig. 4A, B). The apop-
tosis rates of TE671 cells after Aβ treatment were approximately 
22% at 4 hr (data not shown) and 37% at 24 hr (Fig. 4C), respec-
tively. Interestingly, treatment of MβCD resulted in 41% reduc-
tion of Aβ-induced apoptosis after 24 hr. On the contrary, H2O2-
induced apoptosis was rather increased with MβCD treatment. 
These findings suggest that GD3 accumulation, which is mainly 
determined by both its delivery from Golgi complex, the site of 
synthesis, to plasma membrane and the exit from plasma mem-
brane to mitochondria via lipid microdomains, plays a key role 
in Aβ-induced apoptosis.
 
DISCUSSION
We showed here that extracellular Aβ induces GD3 synthase 
expression to increase intracellular GD3 level and that neosyn-
thesized GD3 accumulates in plasma membrane microdomains 
before it is translocated to mitochondria to induce mitochondri-
al damage in TE671 cells. We also demonstrated that blocking 
GD3 accumulation and trafficking in cell surface by MβCD sig-
nificantly prevents Aβ-induced apoptosis, suggesting that cell 
surface GD3 acts as an important step in Aβ-induced apoptosis.
  GD3 has attracted considerable attention due to its role as a 
cell death effector (6, 11). Increased intracellular GD3 are known 
to be required in CD95- and ceramide-induced apoptosis in 
hematopoietic cells (6) as well as TNF-α-induced apoptosis in 
hepatocytes (12) and colon cells (11). GD3 activation has also 
been reported to involve in Aβ-induced apoptosis in cortical 
neurons (9). 
  There are accumulating evidences that GD3 acts as a core in-
tracellular mediator inducing dissipation of the inner mitochon-
drial transmembrane potential through opening the permea-
bility transition pore complex (PTPC) and the release of mito-
chondrial proapoptogenic factors such as cytochrome c, ATP, 
apoptosis inducing factor and mitochondrial caspases (13-15). 
GD3 also elicits a burst of reactive oxygen species production 
from mitochondrial respiratory chain, contributing the apopto-
some activation (16). However, the exact target of GD3 in mito-
chondria still remains to be elucidated. Interestingly, apoptotic 
potential of GD3 is known to be modulated by acetylation and 
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oxidation. Acetylated GD3, especially 9-O-acetyl GD3, is unable 
to elicit, rather suppresses proapoptotic activity of GD3 (17), 
whereas the main product of GD3 oxidation, GD3-7-aldehyde, 
is more efficient to induce PTPC-dependent apoptosis than GD3 
in HL-60 cells (18). 
  Gangliosides are distributed predominantly in the plasma 
membrane and the early Golgi compartment. GM1 and GM3 
are known to be the abundant gangliosides in membrane lipid 
microdomains whereas GD3 is a minor ganglioside in most nor-
mal tissues (19). Gangliosides are synthesized through several 
steps occurring in different intracellular compartments (15). The 
carbon backbone of gangliosides, ceramide, is either de novo 
synthesized in the endoplasmic reticulum or arises from hydro-
lysis of sphingomyelin-engaging sphingomyelinases (SMases). 
Stepwise glucosylation and galactosylation of ceramide occurs 
in the Golgi, producing lacosylceramide. Sequential addition of 
sialic acids to lacosylceramide results in the formation of gan-
gliosides. The α 2,8-sialyl-transferase, called GD3 synthase, is 
known to reside in early Golgi and catalyzes the addition of a 
second sialic acid to GM3 to generate GD3, one of b-series of 
gangliosides (5). In our study, extracellular Aβ induced marked 
expression of GD3 synthase mRNA (Fig. 3). Although it remains 
to be determined whether extracellular Aβ induces GD3 syn-
thase through death receptors in cell membrane, GD3 synthase 
expression is responsible to the increased intracellular GD3 after 
Aβ treatment. As ceramide synthesized by acidic SMase contrib-
utes GD3 generation in TNF-α-mediated apoptosis (11), it is 
worthwhile to evaluate if extracellular Aβ induces acidic SMase 
as well. Sialidases (Neu), key enzymes in the degradation of 
gangliosides, also affect the GD3 concentration in membranes 
(20). It has been demonstrated that the expression level of Neu4 
sialidase dramatically decreases with GD3 accumulation in mi-
tochondria prior to neuronal apoptosis induced by catechol 
metabolites (21).
  Aβ binding and aggregation occurs in the presence of plasma 
membrane lipids, especially cholesterol and gangliosides (22). 
Lipid rafts are specialized membrane domains where numer-
ous receptors with their downstream signaling molecules are 
concentrated (23). This microdomain has higher concentrations 
of cholesterol and gangliosides than any other membrane sub-
structures (24). Several studies have demonstrated that soluble 
extracellular Aβ interacts with gangliosides in the outer leaflet 
of cholesterol-rich lipid rafts to form toxic Aβ aggregation (25). 
In fact, GM1-bound Aβ has been found in brains exhibiting ear-
ly pathologic changes of Alzheimer’s disease (26). We demon-
strated here that GD3, which was not detected in basal condi-
tion, increased with exogenous Aβ and distributed unevenly 
along the cell margin as puncta of different sizes with partial 
colocalization with caveolin-1 (Fig. 3). This finding suggests 
that neosynthesized GD3 localizes in lipid raft microdomains 
including caveolae. Several studies have also shown that GD3 
localizes constitutively in plasma membrane lipid rafts in rat 
cerebellar granular neurons and hepatocytes (12, 27). However, 
in our study, the GD3 level in lipid rafts is not noticeable at bas-
al condition, rather induced with extracellular Aβ. Whether GD3 
in lipid rafts is derived from hydrolysis of sphingomyelin in situ 
or de novo synthesis in the Golgi during Aβ-induced apoptosis 
needs to be determined. 
  Increased GD3 in plasma membrane lipid microdomains 
might facilitate the conformation changes of soluble extracellu-
lar Aβ into toxic Aβ aggregation, which triggers neuronal apop-
tosis. Recently, it has been reported that primary neurons and 
astrocytes isolated from GD3 synthase knockout mice exhibited 
resistance to Aβ-induced cell death and Aβ aggregation (28), 
showing the requirement of GD3 and its synthase in Aβ aggre-
gation and Aβ-induced apoptosis. We also demonstrated here 
that cholesterol depletion in lipid rafts by MβCD prevented not 
only GD3 increase in cell surface but also Aβ-induced apopto-
sis (Fig. 4). These findings, in agreement with other reports, un-
derline the importance of GD3 in lipid microdomains of cell 
membranes in Aβ-triggered apoptosis.
  Copani et al. (9) first reported that GD3 activation involved in 
Aβ-induced apoptosis by reactivating unscheduled cell cycle to 
enter into S-phase in cortical neurons. They showed that neo-
synthesized GD3 accumulated inside the nuclear region, spec-
ulating that GD3 provides nuclear signal for aberrant DNA rep-
lication. Several other studies have also reported that GD3 is 
translocated to nucleus and acts as a repressor of the TNF-in-
ducible NF-κB-dependent induction of survival genes in hepa-
tocytes (29) and induce post-translational modification of his-
tone H1 during anti-CD95 antibody-triggered apoptosis in HUT-
78 cells (30). However, in our experiments using brain-derived 
TE671 cells, nuclear accumulation of GD3 was not observed 
during Aβ-induced apoptosis. Rather, GD3 prominently accu-
mulated in plasma membrane before mitochondrial targeting.
  In summary, our data suggest that rapidly accumulated GD3 
in plasma membrane lipid microdomains, prior to mitochondri-
al translocation in response to extracellular Aβ, might be one of 
the key events in Aβ-induced apoptosis. Inhibition of Aβ-induced 
apoptosis through modulating GD3 accumulation in lipid rafts 
and its trafficking to mitochondria might be a novel therapeutic 
strategy in neurodegenerative diseases related with Aβ pathology.
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